Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22)

Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22), also known as aml with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22), is related to acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or and acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22), and has symptoms including fatigue and fever. An important gene associated with Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22) is CBFB (Core-Binding Factor Subunit Beta), and among its related pathways/superpathways are Signal Transduction and Actin Nucleation by ARP-WASP Complex. The drugs Etoposide and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and myeloid, and related phenotypes are Decreased substrate adherent cell growth and Increased shRNA abundance (Z-score > 2)